NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder

This study has been terminated.

(the study has concluded normally;)

Sponsor:

Information provided by:

University Hospital, Rouen

ClinicalTrials.gov Identifier:

NCT00213577

First received: September 13, 2005

Last updated: March 3, 2008

Last verified: March 2008

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been terminated.
Study Completion Date:	October 2007
Primary Completion Date:	September 2007 (Final data collection date for primary outcome measure)

No publications provided by University Hospital, Rouen

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Grise P, Ruffion A, Denys P, Egon G, Chartier Kastler E. Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses. Eur Urol. 2010 Nov;58(5):759-66. Epub 2010 Jul 3.

To Top